AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01394-06v1
51/8/2979    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steinbach, W. J.
Right arrow Articles by Perfect, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steinbach, W. J.
Right arrow Articles by Perfect, J. R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2007, p. 2979-2981, Vol. 51, No. 8
0066-4804/07/$08.00+0     doi:10.1128/AAC.01394-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Calcineurin Inhibition or Mutation Enhances Cell Wall Inhibitors against Aspergillus fumigatus{triangledown}

William J. Steinbach,1,2* Robert A. Cramer Jr.,2 B. Zachary Perfect,1 Christina Henn,1 Kirsten Nielsen,2 Joseph Heitman,2,3,4 and John R. Perfect2,3

Division of Pediatric Infectious Diseases, Department of Pediatrics,1 Department of Molecular Genetics and Microbiology,2 Division of Infectious Diseases and International Health, Department of Medicine,3 Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 277104

Received 7 November 2006/ Returned for modification 6 January 2007/ Accepted 5 May 2007

Calcineurin mutation or inhibition enhanced the antifungal morphological effect of cell wall inhibitors caspofungin or nikkomycin Z against Aspergillus fumigatus. Quantification of 1,3-ß-D-glucan revealed decreased amounts in the calcineurin A ({Delta}cnaA) mutant. Calcineurin can be an excellent adjunct therapeutic target in combination with other cell wall inhibitors against A. fumigatus.


* Corresponding author. Mailing address: Division of Pediatric Infectious Diseases, Box 3499, Duke University Medical Center, Durham, NC 27710. Phone: (919) 684-3734. Fax: (919) 684-8902. E-mail: stein022{at}mc.duke.edu

{triangledown} Published ahead of print on 14 May 2007.


Antimicrobial Agents and Chemotherapy, August 2007, p. 2979-2981, Vol. 51, No. 8
0066-4804/07/$08.00+0     doi:10.1128/AAC.01394-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.